Navigation Links
Interleukin Genetics Reports First Quarter 2009 Financial Results
Date:5/14/2009

WALTHAM, Mass., May 14 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) today announced financial and operational results for the first quarter ended March 31, 2009.

"In the first quarter we met several of our key corporate objectives. We completed negotiations on a very important research collaboration with a biotech company, presented data from our research related to osteoporosis and obesity at two important scientific conferences, established a European distribution agreement for our Heart Health test product and continued to develop the infrastructure necessary to create our own brand of genetic test products," said Lewis H. Bender, Chief Executive Officer. "Looking ahead to the rest of the year, we are preparing to launch our own genetic test brand, and continue to hold discussions with companies regarding partnering opportunities for our various programs, products, intellectual property and genetic biomarker expertise."

Revenue for the three months ended March 31, 2009, was $1.9 million compared to $2.7 million for the same period in the prior year. The decrease was primarily attributable to the effect current economic conditions have had on consumer product revenue. Genetic test revenue increased this quarter over the same period in the prior year as we experience positive growth in that segment of our business.

Research and development expenses were $0.9 million for the three months ended March 31, 2009 compared to $0.8 million for the same period in the prior year. The increase is primarily attributable to ongoing costs associated with our patent portfolio. In addition, we continue to allocate resources to projects underway with Alticor as well as the development of our own genetic test products.

Selling, general and administrative expenses were $2.0 mill
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. NYSE Amex Accepts Interleukin Genetics Plan to Meet Continued Listing Standards
2. Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
3. Interleukin Genetics Announces Conference Call to Discuss First Quarter 2009 Results
4. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
5. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
6. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
7. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
8. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
9. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
10. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... CA and San Diego, CA (PRWEB) October 27, ... nurse quality indicators database, kicks off its Reliability ... at the U.S. Grant Hotel in downtown San ... experts in a dynamic exchange to advance hospital’s ... , “This year’s conference keynote speakers exemplify the ...
(Date:10/27/2014)... Jiwa Law Corporation now provides Vancouver personal ... motor vehicle accidents. The corporation now assists clients in ... up to a maximum of $150,000. These accident benefits ... medications, home support services, and medical equipment. , ... the way you live your life,” states a company ...
(Date:10/27/2014)... and Atlanta, GA (PRWEB) October 27, 2014 ... cloud-based technologies for the healthcare market, and financial ... offer a fully integrated payment and security solution ... EHR is a cloud-based online, ambulatory Electronic Health ... for small and medium-sized practices. Through the ChARM ...
(Date:10/27/2014)... HealthDay Reporter FRIDAY, Oct. 24, ... hospitals have infection control procedures in place to effectively and ... the 1,039 acute care hospitals that responded to the survey, ... percent said they were "not prepared," according to the Association ... results of the poll paint a disturbing picture, and point ...
(Date:10/27/2014)... Medicines Agency (EMA), an EU agency, has gathered information ... the European ADR database, EudraVigilance. Both authorities and pharmaceutical ... to the database, which provides new knowledge about unknown ... adverse drug reaction reports on asthma medications approved for ... period (2007 to 2011). In the light of the ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders to Address Reliability and Resiliency in Hospitals 2Health News:Jiwa Law Corporation Now Assists Clients With ICBC Claims for Motor Vehicle Accidents 2Health News:MedicalMine and Bluefin Payment Systems Partner for Integrated Patient Payments in the ChARM EHR Software Platform 2Health News:MedicalMine and Bluefin Payment Systems Partner for Integrated Patient Payments in the ChARM EHR Software Platform 3Health News:Few U.S. Hospitals Ready to Handle Ebola, Survey Finds 2Health News:Few U.S. Hospitals Ready to Handle Ebola, Survey Finds 3Health News:Adverse drug reactions in children following use of asthma medications 2
... RIDGE, N.J., Feb. 20 When Avaya ... exhibition show floor of HIMSS08,next week, onboard ... Communications,solutions that are helping healthcare organizations address ... Avaya Inc.,is a leading global provider of ...
... HATBORO, Pa., Feb. 20 InfoLogix, Inc.,(Nasdaq: ... mobility,solutions for the healthcare and commercial industries, announced ... at the Growth & Value,Investor Conference to be ... on,February 27-28, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Existing ... Vendor ... of,point-of-care charge capture technologies, today announced that Kentucky,Medical Services Foundation ... clinician base of more than 600 providers., MedAptus, Professional ...
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced results for the ... Financial highlights, Net sales, Net sales ... million,compared to $28.9 million in the second quarter of ... fiscal 2007. Net sales for the nine months,ended January ...
... Evidence Base for MEDIHONEY(TM) Dressings Growing, PRINCETON, ... Board: DSCI), a provider of advanced wound care ... usage of its,newly released MEDIHONEY(TM) Wound & Burn ... at the upcoming annual,American Professional Wound Care Association ...
... Las Vegas Training Facility, FREMONT, Calif., Feb. ... and aesthetic lasers, today announced an agreement with,The ... an,internationally recognized leader in post-graduate dental education, in,which ... utilized at,LVI,s state-of-the-art teaching facility through 2009. The ...
Cached Medicine News:Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 2Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 3Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 4Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 2Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 3Health News:MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 2Health News:MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 3Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 2Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 3Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 4Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 5Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 6Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 7Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 8Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 9Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 2Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 3Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 4Health News:HOYA ConBio Announces Educational Agreement With LVI Global 2
(Date:10/30/2014)... 29, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, is committed to pursuing ... developed an innovative, patent-pending dual carrier transdermal delivery ... pharmaceutical active ingredients to penetrate the skin and ... The transdermal delivery method also overcomes microbial drug ...
(Date:10/30/2014)... , Oct. 30, 2014 Today Eli ... details of its long-standing technology transfer program to increase ... Begun in 2003, the effort included Lilly donating manufacturing ... in China , India ... South Africa – all MDR-TB ,hot ...
(Date:10/27/2014)... CHICAGO , Oct. 27, 2014  Demonstrations ... and devices are being featured this week in ... 2014 Scientific Assembly where more than 7,000 emergency ... medicine and participating in educational courses. ... back drop of true-to-life emergency department environments, including ...
Breaking Medicine Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Emergency Medicine of the Future Demonstrated at ACEP14 2Emergency Medicine of the Future Demonstrated at ACEP14 3Emergency Medicine of the Future Demonstrated at ACEP14 4Emergency Medicine of the Future Demonstrated at ACEP14 5Emergency Medicine of the Future Demonstrated at ACEP14 6Emergency Medicine of the Future Demonstrated at ACEP14 7Emergency Medicine of the Future Demonstrated at ACEP14 8Emergency Medicine of the Future Demonstrated at ACEP14 9Emergency Medicine of the Future Demonstrated at ACEP14 10Emergency Medicine of the Future Demonstrated at ACEP14 11Emergency Medicine of the Future Demonstrated at ACEP14 12Emergency Medicine of the Future Demonstrated at ACEP14 13Emergency Medicine of the Future Demonstrated at ACEP14 14Emergency Medicine of the Future Demonstrated at ACEP14 15
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: